Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program

INTRODUCTION: The efficacy and safety of insulin degludec/liraglutide (IDegLira) has been evaluated in the Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes (DUAL) phase 3 clinical trial program. In this post hoc analysis, we compared the efficacy and safety of IDegLira in the India...

Descripción completa

Detalles Bibliográficos
Autores principales: Khunti, Kamlesh, Mohan, Viswanathan, Jain, Sunil M., Boesgaard, Trine Welløv, Begtrup, Kamilla, Sethi, Bipin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446379/
https://www.ncbi.nlm.nih.gov/pubmed/28332144
http://dx.doi.org/10.1007/s13300-017-0252-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446379/
https://www.ncbi.nlm.nih.gov/pubmed/28332144
http://dx.doi.org/10.1007/s13300-017-0252-9

Ejemplares similares